Literature DB >> 33551490

COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.

Michela M Fabricius1, Dima Dandachi2.   

Abstract

Convalescent plasma is an old treatment for a new disease. The coronavirus disease 2019 (COVID-19) pandemic caused the analysis of convalescent plasma to reemerge as a possible treatment. First, a systematic review summarizes the available research examining the use of convalescent plasma for the treatment of patients with COVID-19. Second, we describe our experience in establishing a single-center convalescent plasma donation program. Copyright 2021 by the Missouri State Medical Association.

Entities:  

Mesh：

Year:  2021        PMID： 33551490      PMCID： PMC7861598     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  21 in total

1.  Early safety indicators of COVID-19 convalescent plasma in 5,000 patients.

Authors:  Michael J Joyner; R Scott Wright; DeLisa Fairweather; Jonathon W Senefeld; Katelyn A Bruno; Stephen A Klassen; Rickey E Carter; Allan M Klompas; Chad C Wiggins; John Ra Shepherd; Robert F Rea; Emily R Whelan; Andrew J Clayburn; Matthew R Spiegel; Patrick W Johnson; Elizabeth R Lesser; Sarah E Baker; Kathryn F Larson; Juan G Ripoll; Kylie J Andersen; David O Hodge; Katie L Kunze; Matthew R Buras; Matthew Np Vogt; Vitaly Herasevich; Joshua J Dennis; Riley J Regimbal; Philippe R Bauer; Janis E Blair; Camille M van Buskirk; Jeffrey L Winters; James R Stubbs; Nigel S Paneth; Nicole C Verdun; Peter Marks; Arturo Casadevall
Journal:  J Clin Invest       Date:  2020-06-11       Impact factor: 14.808

2.  Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.

Authors:  Ling Li; Wei Zhang; Yu Hu; Xunliang Tong; Shangen Zheng; Juntao Yang; Yujie Kong; Lili Ren; Qing Wei; Heng Mei; Caiying Hu; Cuihua Tao; Ru Yang; Jue Wang; Yongpei Yu; Yong Guo; Xiaoxiong Wu; Zhihua Xu; Li Zeng; Nian Xiong; Lifeng Chen; Juan Wang; Ning Man; Yu Liu; Haixia Xu; E Deng; Xuejun Zhang; Chenyue Li; Conghui Wang; Shisheng Su; Linqi Zhang; Jianwei Wang; Yanyun Wu; Zhong Liu
Journal:  JAMA       Date:  2020-08-04       Impact factor: 56.272

3.  Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.

Authors:  Niveditha Devasenapathy; Zhikang Ye; Mark Loeb; Fang Fang; Borna Tadayon Najafabadi; Yingqi Xiao; Rachel Couban; Philippe Bégin; Gordon Guyatt
Journal:  CMAJ       Date:  2020-05-22       Impact factor: 8.262

Review 4.  Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?

Authors:  Pierre Tiberghien; Xavier de Lamballerie; Pascal Morel; Pierre Gallian; Karine Lacombe; Yazdan Yazdanpanah
Journal:  Vox Sang       Date:  2020-04-02       Impact factor: 2.144

5.  Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

Authors:  Chenguang Shen; Zhaoqin Wang; Fang Zhao; Yang Yang; Jinxiu Li; Jing Yuan; Fuxiang Wang; Delin Li; Minghui Yang; Li Xing; Jinli Wei; Haixia Xiao; Yan Yang; Jiuxin Qu; Ling Qing; Li Chen; Zhixiang Xu; Ling Peng; Yanjie Li; Haixia Zheng; Feng Chen; Kun Huang; Yujing Jiang; Dongjing Liu; Zheng Zhang; Yingxia Liu; Lei Liu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

Review 6.  Deployment of convalescent plasma for the prevention and treatment of COVID-19.

Authors:  Evan M Bloch; Shmuel Shoham; Arturo Casadevall; Bruce S Sachais; Beth Shaz; Jeffrey L Winters; Camille van Buskirk; Brenda J Grossman; Michael Joyner; Jeffrey P Henderson; Andrew Pekosz; Bryan Lau; Amy Wesolowski; Louis Katz; Hua Shan; Paul G Auwaerter; David Thomas; David J Sullivan; Nigel Paneth; Eric Gehrie; Steven Spitalnik; Eldad A Hod; Lewis Pollack; Wayne T Nicholson; Liise-Anne Pirofski; Jeffrey A Bailey; Aaron Ar Tobian
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

7.  Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.

Authors:  Qing-Lei Zeng; Zu-Jiang Yu; Jian-Jun Gou; Guang-Ming Li; Shu-Huan Ma; Guo-Fan Zhang; Jiang-Hai Xu; Wan-Bao Lin; Guang-Lin Cui; Min-Min Zhang; Cheng Li; Ze-Shuai Wang; Zhi-Hao Zhang; Zhang-Suo Liu
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

8.  Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.

Authors:  Johan van Griensven; Tansy Edwards; Xavier de Lamballerie; Malcolm G Semple; Pierre Gallian; Sylvain Baize; Peter W Horby; Hervé Raoul; N'Faly Magassouba; Annick Antierens; Carolyn Lomas; Ousmane Faye; Amadou A Sall; Katrien Fransen; Jozefien Buyze; Raffaella Ravinetto; Pierre Tiberghien; Yves Claeys; Maaike De Crop; Lutgarde Lynen; Elhadj Ibrahima Bah; Peter G Smith; Alexandre Delamou; Anja De Weggheleire; Nyankoye Haba
Journal:  N Engl J Med       Date:  2016-01-07       Impact factor: 91.245

Review 9.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226

10.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.

Authors:  Alexandra C Walls; Young-Jun Park; M Alejandra Tortorici; Abigail Wall; Andrew T McGuire; David Veesler
Journal:  Cell       Date:  2020-03-09       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.